Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.

Cancers (Basel) · 2018 · PMC6266947 · PMID 30445772

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A previous pilot study showed a trend towards a higher exposure to buccally delivered fentanyl in patients with mucositis compared to patients without mucositis [ 21 ], while another study showed no differences [ 22 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.